Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate RiskSuzanne J. Baron, Kaijun Wang, John A. House et al.|Circulation|2019Cited by 182
Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical RiskSuzanne J. Baron, Suzanne V. Arnold, Kaijun Wang et al.|JAMA Cardiology|2017Cited by 142
Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic StenosisSuzanne J. Baron, David J. Cohen, Elizabeth A. Magnuson et al.|Journal of the American College of Cardiology|2019Cited by 90
Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER TrialSamir Kapadia, Martin B. Leon, Chetan Huded et al.|Journal of the American College of Cardiology|2018Cited by 77
Efficacy and safety of argatroban with or without glycoprotein IIb/IIIa inhibitor in patients with heparin induced thrombocytopenia undergoing percutaneous coronary intervention for acute coronary syndromeIgnacio Cruz‐González, Ik‐Kyung Jang, María Sánchez Ledesma et al.|Journal of Thrombosis and Thrombolysis|2007Cited by 30